Milk fat globule-EGF factor VIII in sepsis and ischemia- reperfusion injury

Molecular Medicine

Volumn 17, Issue 1-2, 2011, Pages 126-133

  Matsuda, Akihisa ^a,b   Jacob, Asha ^a,b   Wu, Rongqian ^a,b   Zhou, Mian ^a,b   Nicastro, Jeffrey M ^b   Coppa, Gene F ^b   Wang, Ping ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FRACTALKINE; LACTADHERIN; OPSONIN; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE LUNG INJURY; APOPTOSIS; ARTICLE; CAUSE OF DEATH; CELL DEATH; CRITICALLY ILL PATIENT; DRUG MECHANISM; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTESTINE ISCHEMIA; ISCHEMIA; MACROPHAGE; MOLECULAR MECHANICS; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPERFUSION INJURY; SEPSIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY;

ANTIGENS, SURFACE; HUMANS; INFLAMMATION; MILK PROTEINS; REPERFUSION INJURY; SEPSIS;

EID: 78651484733     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00135     Document Type: Article

References (96)

1. Oberholzer A, Oberholzer C, Moldawer LL. (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 16:83-96.
2. Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care. Med. 29:1303-10.
3. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:879-92.
4. Riedemann NC, Guo RF, Ward PA. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9:517-24.
5. van den Berghe G, et al. (2001) Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-67.
6. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. (2004) The role of the complement system in ischemia-reperfusion injury. Shock. 21:401-9.
7. Carden DL, Granger DN. (2000) Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190:255-66.
8. Neary P, Redmond HP. (1999) Ischaemia-reperfusion injury and the systemic inflammatory response syndrome. In: Ischaemia-Reperfusion Injury. Grace PA, Mathie RT (ed.) Blackwell Science, London, pp. 123-6.
9. Stubbs JD, et al. (1990) cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc. Natl. Acad. Sci. U. S. A. 87:8417-21.
10. Bu HF, et al. (2007) Milk fat globule-EGF factor 8/ lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J. Clin. Invest. 117:3673-83.
11. Ensslin MA, Shur BD. (2003) Identification of mouse sperm SED1, a bimotif EGF repeat and discoidin-domain protein involved in sperm-egg binding. Cell. 114:405-17.
12. Hanayama R, Nagata S. (2005) Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc. Natl. Acad. Sci. U. S. A. 102:16886-91.
13. Hanayama R, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature. 417:182-7.
14. Hanayama R, et al. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFGE8-deficient mice. Science. 304:1147-50.
15. Silvestre JS, et al. (2005) Lactadherin promotes VEGF-dependent neovascularization. Nat. Med. 11:499-506.
16. Aoki N, et al. (1995) Molecular cloning of glycoprotein antigens MGP57/53 recognized by monoclonal antibodies raised against bovine milk fat globule membrane. Biochim. Biophys. Acta. 1245:385-91.
17. Couto JR, Taylor MR, Godwin SG, Ceriani RL, Peterson JA. (1996) Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell. Biol. 15:281-6.
18. Hvarregaard J, Andersen MH, Berglund L, Rasmussen JT, Petersen TE. (1996) Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur. J. Biochem. 240:628-36.
19. Larocca D, et al. (1991) A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res. 51:4994-8.
20. Aziz MM, et al. (2009) MFG-E8 attenuates intestinal inflammation in murine experimental colitis by modulating osteopontin-dependent alphavbeta3 integrin signaling. J. Immunol. 182:7222-32.
21. Andersen MH, Graversen H, Fedosov SN, Petersen TE, Rasmussen JT. (2000) Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry. 39:6200-6.
22. Raymond A, Ensslin MA, Shur BD. (2009) SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions. J. Cell. Biochem. 106:957-66.
23. Taylor MR, Couto JR, Scallan CD, Ceriani RL, Peterson JA. (1997) Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell. Biol. 16:861-9.
24. Oshima K, et al. (1999) Lactation-dependent expression of an mRNA splice variant with an exon for a multiply O-glycosylated domain of mouse milk fat globule glycoprotein MFG-E8. Biochem. Biophys. Res. Commun. 254:522-8.
25. Burgess BL, Abrams TA, Nagata S, Hall MO. (2006) MFG-E8 in the retina and retinal pigment epithelium of rat and mouse. Mol. Vis. 12:1437-47.
26. Asano K, et al. (2004) Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200:459-67.
27. Miyasaka K, Hanayama R, Tanaka M, Nagata S. (2004) Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells. Eur. J. Immunol. 34:1414-22.
28. Watanabe T, et al. (2005) Production of the long and short forms of MFG-E8 by epidermal keratinocytes. Cell Tissue Res. 321:185-93.
29. Jinushi M, et al. (2007) MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J. Clin. Invest. 117:1902-13.
30. Leonardi-Essmann F, Emig M, Kitamura Y, Spanagel R, Gebicke-Haerter PJ. (2005) Fractalkineupregulated milk-fat globule EGF factor-8 protein in cultured rat microglia. J. Neuroimmunol. 160:92-101.
31. Miksa M, Amin D, Wu R, Ravikumar TS, Wang P. (2007) Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages. Mol. Med. 13:553-60.
32. Boddaert J, et al. (2007) Evidence of a role for lactadherin in Alzheimer's disease. Am. J. Pathol. 170:921-9.
33. Ait-Oufella H, et al. (2007) Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 115:2168-77.
34. Komura H, Miksa M, Wu R, Goyert SM, Wang P. (2009) Milk fat globule epidermal growth factorfactor VIII is downregulated in sepsis via the lipopolysaccharide-CD14 pathway. J. Immunol. 182:581-7.
35. Miksa M, et al. (2006) Dendritic cell-derived exosomes containing milk fat globule epidermal growth factor-factor VIII attenuate proinflammatory responses in sepsis. Shock. 25:586-93.
36. Miksa M, et al. (2009) Immature dendritic cellderived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII. J. Immunol. 183:5983-90; erratum 2009;183:8295.
37. Cui T, et al. (2010) Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am. J. Respir. Crit. Care. Med. 181:238-46.
38. Matsuda A, et al. (2010) The renoprotective effect of Milk Fat Globule EGF-Factor VIII after ischemia and reperfusion injury in mice. Shock. 33(Suppl 1):53.
39. Yamaguchi H, et al. (2008) Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J. Leukoc. Biol. 83:1300-7.
40. Atabai K, et al. (2009) Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. J. Clin. Invest. 119:3713-22.
41. Jinushi M, et al. (2008) Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res. 68:8889-98.
42. Henson PM, Hume DA. (2006) Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27:244-50.
43. Henson PM, Bratton DL, Fadok VA. (2001) Apoptotic cell removal. Curr. Biol. 11: R795-805.
44. Savill J, Dransfield I, Gregory C, Haslett C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-75.
45. Wu Y, Tibrewal N, Birge RB. (2006) Phosphatidyl - serine recognition by phagocytes: a view to a kill. Trends Cell Biol. 16:189-97.
46. Fadok VA, et al. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:85-90.
47. Oka K, et al. (1998) Lectin-like oxidized lowdensity lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95:9535-40.
48. Kawasaki Y, Nakagawa A, Nagaosa K, Shiratsuchi A, Nakanishi Y. (2002) Phosphatidylserine binding of class B scavenger receptor type I, a phagocytosis receptor of testicular sertoli cells. J. Biol. Chem. 277:27559-66.
49. Anderson HA, et al. (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4:87-91.
50. Fink SL, Cookson BT. (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1907-16.
51. Bell CW, Jiang W, Reich CF, 3rd, Pisetsky DS. (2006) The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291: C1318-C1325.
52. Munoz LE, et al. (2005) SLE-a disease of clearance deficiency? Rheumatology (Oxford). 44:1101-7.
53. Silva MT, do Vale A, dos Santos NM. (2008) Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis. 13:463-82.
54. Zheng L, He M, Long M, Blomgran R, Stendahl O. (2004) Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J. Immunol. 173:6319-6326.
55. Hotchkiss RS, et al. (2003) Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. U. S. A. 100:6724-679.
56. Henson PM. (2005) Dampening inflammation. Nat. Immunol. 6:1179-1181.
57. Fadok VA, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:890-8.
58. Voll RE, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature. 390:350-1.
59. Monks J, et al. (2005) Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ. 12:107-14.
60. Miksa M, et al. (2008) Maturation-induced downregulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response. Int. J. Mol. Med. 22:743-8.
61. Chung CS, Xu YX, Chaudry IH, Ayala A. (1998) Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression. J. Surg. Res. 77:63-70.
62. Hotchkiss RS, Nicholson DW. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6:813-22.
63. Wang SD, Huang KJ, Lin YS, Lei HY. (1994) Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152:5014-21.
64. Miksa M, Komura H, Wu R, Shah KG, Wang P. (2009) A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester. J. Immunol. Methods. 342:71-7.
65. Chaudry IH. (1999) Sepsis: lessons learned in the last century and future directions. Arch. Surg. 134:922-9.
66. Deitch EA. (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9:1-11.
67. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN. (2001) Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect. Immun. 69:7271-6.
68. Li P, et al. (1995) Mice deficient in IL-1 betaconverting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 80:401-11.
69. Lotze MT, Tracey KJ. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-42.
70. Meyer TA, et al. (1995) Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery. 118:336-42.
71. Tracey KJ, et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:662-4.
72. Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248-51.
73. Qin S, et al. (2006) Role of HMGB1 in apoptosismediated sepsis lethality. J. Exp. Med. 203:1637-42.
74. Levonen AL, Vahakangas E, Koponen JK, Yla-Herttuala S. (2008) Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation. 117:2142-50.
75. Thurman JM. (2007) Triggers of inflammation after renal ischemia/reperfusion. Clin. Immunol. 123:7-13.
76. Arumugam TV, et al. (2006) Complement mediators in ischemia-reperfusion injury. Clin. Chim. Acta. 374:33-45.
77. Huk I, et al. (2000) Prostaglandin E1 reduces ischemia/ reperfusion injury by normalizing nitric oxide and superoxide release. Shock. 14:234-42.
78. Zingarelli B, et al. (2007) Diverse cardioprotective signaling mechanisms of peroxisome proliferatoractivated receptor-gamma ligands, 15-deoxy- Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. Shock. 28:554-63.
79. Vedder NB, et al. (1990) Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc. Natl. Acad. Sci. U. S. A. 87:2643-6.
80. Winn RK, Ramamoorthy C, Vedder NB, Sharar S R, Harlan J M. (1997) Leukocyte-endothelial cell interactions in ischemia-reperfusion injury. Ann. N. Y. Acad. Sci. 832:311-21.
81. Chen CH, Liu K, Chan JY. (2008) Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity. Shock. 29:300-8.
82. Rivo J, et al. (2007) Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock. 27:266-73.
83. Wei Q, Yin XM, Wang MH, Dong Z. (2006) Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice. Am. J. Physiol. Renal Physiol. 290: F35-42.
84. Steffens S, Montecucco F, Mach F. (2009) The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb. Haemost. 102:240-7.
85. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH. (2009) Inflammatory mediators of liver ischemia-reperfusion injury. Exp. Clin. Transplant. 7:78-93.
86. Wanderer AA. (2008) Ischemic-reperfusion syndromes: biochemical and immunologic rationale for IL-1 targeted therapy. Clin. Immunol. 128:127-32.
87. An S, Hishikawa Y, Liu J, Koji T. (2007) Lung injury after ischemia-reperfusion of small intestine in rats involves apoptosis of type II alveolar epithelial cells mediated by TNF-alpha and activation of Bid pathway. Apoptosis. 12:1989-2001.
88. Collange O, et al. (2005) Pulmonary apoptosis after supraceliac aorta clamping in a rat model. J. Surg. Res. 129:190-5.
89. Kelly KJ. (2003) Distant effects of experimental renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14:1549-58.
90. Hanayama R, Miyasaka K, Nakaya M, Nagata S. (2006) MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure. Curr. Dir. Autoimmun. 9:162-72.
91. Hart SP, Dransfield I, Rossi AG. (2008) Phagocytosis of apoptotic cells. Methods. 44:280-5.
92. Tendler DA. (2003) Acute intestinal ischemia and infarction. Semin. Gastrointest. Dis. 14:66-76.
93. Matthay MA, et al. (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care. Med. 167:1027-35.
94. Martin TR, Nakamura M, Matute-Bello G. (2003) The role of apoptosis in acute lung injury. Crit. Care. Med. 31:S184-8.
95. Perl M, Lomas-Neira J, Chung CS, Ayala A. (2008) Epithelial cell apoptosis and neutrophil recruitment in acute lung injury - a unifying hypothesis? What we have learned from small interfering RNAs. Mol. Med. 14:465-75.
96. Swan R, et al. (2007) Polymicrobial sepsis enhances clearance of apoptotic immune cells by splenic macrophages. Surgery. 142:253-61.